These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 6345390)

  • 1. Association of bacterial carbohydrate-specific cold agglutinin antibody production with immunization by group C, group B type III, and Streptococcus pneumoniae type XIV streptococcal vaccines.
    Colling RG; Pearson TC; Brown JC
    Infect Immun; 1983 Jul; 41(1):205-13. PubMed ID: 6345390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Properties of cold agglutinin and group carbohydrate-specific antibodies isolated from group C streptococcal antisera.
    Brown JC; Colling RG
    Mol Immunol; 1982 Mar; 19(3):457-65. PubMed ID: 7099171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactivity with rabbit immunoglobulin G of cold agglutinins isolated from group C streptococcal antisera.
    Colling RG; Brown JC
    Infect Immun; 1981 Dec; 34(3):828-34. PubMed ID: 6174452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and characterization of murine monoclonal antibodies that express both cold agglutinin and cryoglobulin activities.
    Patel RD; Brown JC
    J Immunol; 1985 Jun; 134(6):4041-7. PubMed ID: 3989304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Horse anti-type XIV Pneumococcus sera behave as cold agglutinins recognizing developmentally regulated antigens apart from the Ii antigens on human erythrocytes.
    Pennington J; Feizi T
    Vox Sang; 1982 Nov; 43(5):253-8. PubMed ID: 7147858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The appearance of IgM and IgG cold agglutinins in rabbits hyperimmunized with group C streptococcal vaccine.
    Colling RG; Brown JC
    J Immunol; 1979 Jan; 122(1):202-8. PubMed ID: 84018
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunodeterminant specificity of human immunity to type III group B streptococcus.
    Kasper DL; Baker CJ; Baltimore RS; Crabb JH; Schiffman G; Jennings HJ
    J Exp Med; 1979 Feb; 149(2):327-39. PubMed ID: 84042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type III group B streptococcal polysaccharide induces antibodies that cross-react with Streptococcus pneumoniae type 14.
    Guttormsen HK; Baker CJ; Nahm MH; Paoletti LC; Zughaier SM; Edwards MS; Kasper DL
    Infect Immun; 2002 Apr; 70(4):1724-38. PubMed ID: 11895934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of stimulation of isohemagglutinin antibodies by immunization with group B streptococcal (type III) vaccine.
    Webb BJ; Kasper DL; Baker CJ
    J Pediatr; 1981 Dec; 99(6):918-20. PubMed ID: 7031212
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus.
    Wessels MR; Paoletti LC; Kasper DL; DiFabio JL; Michon F; Holme K; Jennings HJ
    J Clin Invest; 1990 Nov; 86(5):1428-33. PubMed ID: 2243123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demonstration of opsonic activity and in vivo protection against group B streptococci type III by Streptococcus pneumoniae type 14 antisera.
    Fischer GW; Lowell GH; Crumrine MH; Bass JW
    J Exp Med; 1978 Sep; 148(3):776-86. PubMed ID: 29937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of group B streptococcal type-specific polysaccharides with wheat germ agglutinin and other lectins.
    Gray BM; Dillon HC; Pritchard DG
    J Immunol Methods; 1984 Aug; 72(1):269-77. PubMed ID: 6205097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoprecipitation and opsonic cross-reaction between type-14 pneumococcus and group-B streptococcus type III.
    Fischer GW; Lowell GH; Crumrine MH; Wilson SR
    Lancet; 1979 Jan; 1(8107):75-7. PubMed ID: 84130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cold hemagglutinin cross-reactivity with Mycoplasma pneumoniae.
    Janney FA; Lee LT; Howe C
    Infect Immun; 1978 Oct; 22(1):29-33. PubMed ID: 83298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal immunization of mice with group B streptococcal type III polysaccharide-beta C protein conjugate elicits protective antibody to multiple serotypes.
    Madoff LC; Paoletti LC; Tai JY; Kasper DL
    J Clin Invest; 1994 Jul; 94(1):286-92. PubMed ID: 7518832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epitope specificity of rabbit immunoglobulin G (IgG) elicited by pneumococcal type 23F synthetic oligosaccharide- and native polysaccharide-protein conjugate vaccines: comparison with human anti-polysaccharide 23F IgG.
    Alonso de Velasco E; Verheul AF; van Steijn AM; Dekker HA; Feldman RG; Fernández IM; Kamerling JP; Vliegenthart JF; Verhoef J; Snippe H
    Infect Immun; 1994 Mar; 62(3):799-808. PubMed ID: 7509318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occurrence of 19S and 7S anti-IgGs during hyperimmunization of rabbits with streptococci.
    Bokisch VA; Bernstein D; Krause RM
    J Exp Med; 1972 Oct; 136(4):799-815. PubMed ID: 4403474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cold agglutinin antibody in a hyperimmune erythrocyte antiserum.
    Warber KD; Brown JC
    Proc Soc Exp Biol Med; 1982 Oct; 171(1):7-11. PubMed ID: 6183669
    [No Abstract]   [Full Text] [Related]  

  • 19. Conjugate vaccines against group B Streptococcus types IV and VII.
    Paoletti LC; Kasper DL
    J Infect Dis; 2002 Jul; 186(1):123-6. PubMed ID: 12089673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of protective antibodies against type Ia and Ib group B streptococci by a type Ia polysaccharide-tetanus toxoid conjugate vaccine.
    Wessels MR; Paoletti LC; Rodewald AK; Michon F; DiFabio J; Jennings HJ; Kasper DL
    Infect Immun; 1993 Nov; 61(11):4760-6. PubMed ID: 8406875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.